FDA Inspection 1022686 — AstraZeneca Pharmaceuticals, LP
The FDA completed an inspection of AstraZeneca Pharmaceuticals, LP on Aug 24, 2017 in Newark, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 2 citations were issued during this inspection. Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 24, 2017
- Fiscal Year
- 2017
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Newark, DE (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1105 | 21 CFR 211.22(d) | Procedures not in writing, fully followed |
| 2419 | 21 CFR 211.198(a) | Complaint Handling Procedure |